Tedaviye Dirençli Distimik Bozuklukta Pramipeksol ile Güçlendirme Tedavisi: Olgu Sunumu.
- Published in:
- Klinik Psikofarmakoloji Bulteni, 2009, v. 19, p. S198
- By:
- Publication type:
- Article
Works matching DE "PRAMIPEXOLE"
Results: 313
1
2
Trial of ropinirole for depression fails to yield significant improvement.
- Published in:
- Brown University Psychopharmacology Update, 2019, v. 30, n. 4, p. 8, doi. 10.1002/pu.30418
- Publication type:
- Article
3
Electrospun cellulose acetate wound dressings loaded with Pramipexole for diabetic wound healing: an in vitro and in vivo study.
- Published in:
- Cellulose, 2022, v. 29, n. 6, p. 3407, doi. 10.1007/s10570-022-04466-0
- By:
- Publication type:
- Article
4
Formulation and in vitro evaluation of pramipexole orally disintegrating tablets for pediatric restless leg syndrome.
- Published in:
- Journal of Research in Pharmacy, 2023, v. 27, n. 5, p. 1808, doi. 10.29228/jrp.465
- By:
- Publication type:
- Article
5
Periodic leg movements during sleep in PLMD and RLS patients with and without pramipexole treatment.
- Published in:
- Somnologie, 2013, v. 17, n. 4, p. 266, doi. 10.1007/s11818-013-0622-0
- By:
- Publication type:
- Article
6
Comparative safety signals of dopamine agonists: psychiatric and cardiovascular risks derived from FDA adverse event reporting system (FAERS) data.
- Published in:
- BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00886-3
- By:
- Publication type:
- Article
7
Delusional infestation caused by pramipexole.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
8
Comparison of the Risk of Adverse Events with Pramipexole and Ropinirole in Patients with Parkinson’s Disease: A Meta-Analysis.
- Published in:
- Drug Safety, 2003, v. 26, n. 6, p. 439, doi. 10.2165/00002018-200326060-00005
- By:
- Publication type:
- Article
9
Pramipexole vs Levodopa as Initial Treatment for Parkinson Disease.
- Published in:
- JAMA: Journal of the American Medical Association, 2000, v. 284, n. 15, p. 1931, doi. 10.1001/jama.284.15.1931
- Publication type:
- Article
10
Efficacy screening trials of paroxetine, pentoxifylline, riluzole, pramipexole and venlafaxine in cocaine dependence.
- Published in:
- Addiction, 2005, v. 100, p. 12, doi. 10.1111/j.1360-0443.2005.00985.x
- By:
- Publication type:
- Article
11
Effectiveness of Deep Brain Stimulation in Iraqi Patients with Parkinson Disease.
- Published in:
- Indian Journal of Forensic Medicine & Toxicology, 2020, v. 14, n. 4, p. 9249, doi. 10.37506/ijfmt.v14i4.13194
- By:
- Publication type:
- Article
12
Restless genital syndrome in a male patient relieved by pramipaxol and gabapentin.
- Published in:
- 2015
- By:
- Publication type:
- Case Study
13
Comparison of pramipexole and citalopram in the treatment of depression in Parkinson's disease: A randomized parallel-group trial.
- Published in:
- Journal of Research in Medical Sciences, 2022, v. 27, n. 7, p. 1, doi. 10.4103/jrms.jrms_790_21
- By:
- Publication type:
- Article
14
Long-Term Use of Pramipexole in Bipolar Depression: A Naturalistic Retrospective Chart Review.
- Published in:
- Psychiatric Quarterly, 2010, v. 81, n. 3, p. 207, doi. 10.1007/s11126-010-9130-6
- By:
- Publication type:
- Article
15
Pramipexole in the treatment of unipolar and bipolar depression. A systematic review and meta‐analysis.
- Published in:
- Acta Psychiatrica Scandinavica, 2019, v. 140, n. 2, p. 116, doi. 10.1111/acps.13055
- By:
- Publication type:
- Article
16
LC–MS/MS and NMR Characterization of Key Impurities in Linagliptin and Pramipexole.
- Published in:
- Journal of Liquid Chromatography & Related Technologies, 2015, v. 38, n. 19, p. 1699, doi. 10.1080/10826076.2015.1087861
- By:
- Publication type:
- Article
17
Estimation of Pramipexole Dihydrochloride in Tablet Formulation by the Developed Reverse Phase High Performance Liquid Chromatography Method and its Validation.
- Published in:
- Indian Journal of Pharmaceutical Sciences, 2022, v. 84, n. 1, p. 228, doi. 10.36468/pharmaceutical-sciences.915
- By:
- Publication type:
- Article
18
Long-term retention rate of pramipexole in the treatment of Parkinson’s disease.
- Published in:
- 2009
- By:
- Publication type:
- Letter
19
Association of the DRD2 and DRD3 polymorphisms with response to pramipexole in Parkinson’s disease patients.
- Published in:
- European Journal of Clinical Pharmacology, 2009, v. 65, n. 7, p. 679, doi. 10.1007/s00228-009-0658-z
- By:
- Publication type:
- Article
20
Discontinuation of ropinirole and pramipexole in patients with Parkinson’s disease: clinical practice versus clinical trials.
- Published in:
- European Journal of Clinical Pharmacology, 2008, v. 64, n. 10, p. 1021, doi. 10.1007/s00228-008-0518-2
- By:
- Publication type:
- Article
21
Syndrom bolestiplných dolních končetin a pohyblivých prstců – dvě kazuistiky.
- Published in:
- Česká a Slovenská Neurologie a Neurochirurgie, 2024, v. 87, n. 3, p. 223
- By:
- Publication type:
- Article
22
Pramipexole differentially modulates fronto-striatal circuits in addictive and compulsive disorders.
- Published in:
- European Psychiatry, 2020, v. 63, p. S293
- By:
- Publication type:
- Article
23
Synthesis of Some New Thiazole, Thiophene, and 2,3-Dihydro-1,3,4-thiadiazole and Pyrimidino[1,2-b]indazole Derivatives.
- Published in:
- Phosphorus, Sulfur & Silicon & the Related Elements, 2005, v. 180, n. 10, p. 2361, doi. 10.1080/104265090921083
- By:
- Publication type:
- Article
24
SYNTHESIS OF SOME NEW THIAZOLIDIN-5-ONE DERIVATIVES OF PHARMACEUTICAL INTEREST.
- Published in:
- Phosphorus, Sulfur & Silicon & the Related Elements, 2004, v. 179, n. 10, p. 2067, doi. 10.1080/10426500490474932
- By:
- Publication type:
- Article
25
Reactions of Trifluoromethylsulfenyl Chloride and Trifluoromethylthiocopper with 2-(Trimethylsilyl)thiazole.
- Published in:
- Phosphorus, Sulfur & Silicon & the Related Elements, 2002, v. 177, n. 10, p. 2465, doi. 10.1080/10426500214306
- By:
- Publication type:
- Article
26
Impulse control disorders in Parkinson's disease patients treated with pramipexole and ropinirole: a systematic review and meta-analysis.
- Published in:
- Neurological Sciences, 2024, v. 45, n. 4, p. 1399, doi. 10.1007/s10072-023-07254-1
- By:
- Publication type:
- Article
27
The benefits of pramipexole selection in the treatment of Parkinson's disease.
- Published in:
- Neurological Sciences, 2014, v. 35, n. 10, p. 1505, doi. 10.1007/s10072-014-1891-5
- By:
- Publication type:
- Article
28
Postural control in restless legs syndrome with medication intervention using pramipexole.
- Published in:
- Neurological Sciences, 2014, v. 35, n. 2, p. 199, doi. 10.1007/s10072-013-1478-6
- By:
- Publication type:
- Article
29
Pathological gambling plus hypersexuality in restless legs syndrome: a new case.
- Published in:
- Neurological Sciences, 2011, v. 32, n. 4, p. 707, doi. 10.1007/s10072-011-0605-5
- By:
- Publication type:
- Article
30
Dopamine agonist-based strategies in the treatment of Parkinson’s disease.
- Published in:
- Neurological Sciences, 2008, v. 29, p. 371, doi. 10.1007/s10072-008-1049-4
- By:
- Publication type:
- Article
31
The treatment of restless legs syndrome.
- Published in:
- Neurological Sciences, 2007, v. 28, p. S61, doi. 10.1007/s10072-007-0739-7
- By:
- Publication type:
- Article
32
Assessment of Repetitive and Compulsive Behaviors Induced by Pramipexole in Rats: Effect of Alpha-Synuclein-Induced Nigrostriatal Degeneration.
- Published in:
- Biomedicines, 2022, v. 10, n. 3, p. 542, doi. 10.3390/biomedicines10030542
- By:
- Publication type:
- Article
33
Effects of pramipexole treatment on the α-synuclein content in serum exosomes of Parkinson's disease patients.
- Published in:
- Experimental & Therapeutic Medicine, 2016, v. 12, n. 3, p. 1373, doi. 10.3892/etm.2016.3471
- By:
- Publication type:
- Article
34
El Pramipexol en el Tratamiento de la Enfermedad de Parkinson.
- Published in:
- Informe Medico, 2012, v. 14, n. 3, p. 111
- By:
- Publication type:
- Article
35
Management of Restless Legs Syndrome in Patients on Dialysis.
- Published in:
- Drugs, 2006, v. 66, n. 5, p. 607, doi. 10.2165/00003495-200666050-00003
- By:
- Publication type:
- Article
36
Dopamine D2R Agonist-Induced Cardiovascular Effects in Healthy Male Subjects: Potential Implications in Clinical Settings.
- Published in:
- ISRN Otolaryngology, 2014, p. 1, doi. 10.1155/2014/956353
- By:
- Publication type:
- Article
37
3D Printed Mini-Floating-Polypill for Parkinson's Disease: Combination of Levodopa, Benserazide, and Pramipexole in Various Dosing for Personalized Therapy.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 5, p. 931, doi. 10.3390/pharmaceutics14050931
- By:
- Publication type:
- Article
38
Precise Dosing of Pramipexole for Low-Dosed Filament Production by Hot Melt Extrusion Applying Various Feeding Methods.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 1, p. 216, doi. 10.3390/pharmaceutics14010216
- By:
- Publication type:
- Article
39
Solid Microneedles for Transdermal Delivery of Amantadine Hydrochloride and Pramipexole Dihydrochloride.
- Published in:
- Pharmaceutics, 2015, v. 7, n. 4, p. 379, doi. 10.3390/pharmaceutics7040379
- By:
- Publication type:
- Article
40
Optimization of Pramipexole-Loaded In Situ Thermosensitive Intranasal Gel for Parkinson's Disease.
- Published in:
- Pharmaceuticals (14248247), 2024, v. 17, n. 2, p. 172, doi. 10.3390/ph17020172
- By:
- Publication type:
- Article
41
An Experimental Medicine Investigation of the Effects of Subacute Pramipexole Treatment on Emotional Information Processing in Healthy Volunteers.
- Published in:
- Pharmaceuticals (14248247), 2021, v. 14, n. 8, p. 800, doi. 10.3390/ph14080800
- By:
- Publication type:
- Article
42
Reliability, validity, and responsiveness of the Japanese version of International Restless Legs Syndrome Study Group rating scale for restless legs syndrome in a clinical trial setting.
- Published in:
- Psychiatry & Clinical Neurosciences, 2013, v. 67, n. 6, p. 412, doi. 10.1111/pcn.12074
- By:
- Publication type:
- Article
43
Pramipexole-induced psychosis in Parkinson's disease.
- Published in:
- 2008
- By:
- Publication type:
- Letter
44
Effect of Pulsed Direct Current on Iontophoretic Delivery of Pramipexole across Human Epidermal Membrane In Vitro.
- Published in:
- Pharmaceutical Research, 2021, v. 38, n. 7, p. 1187, doi. 10.1007/s11095-021-03055-3
- By:
- Publication type:
- Article
45
The Acute Effects of a Dopamine D3 Receptor Preferring Agonist on Motivation for Cigarettes in Dependent and Occasional Cigarette Smokers.
- Published in:
- 2018
- By:
- Publication type:
- journal article
46
Evaluation of electrophysiological changes before and after pramipexole treatment in patients diagnosed with idiopathic restless legs syndrome.
- Published in:
- Clinical Neuroscience / Ideggyógyászati Szemle, 2025, v. 78, n. 1/2, p. 37, doi. 10.18071/isz.78.0037
- By:
- Publication type:
- Article
47
COMPARISON OF PRAMIPEXOLE VERSUS ROPINIROLE IN THE TREATMENT OF PARKINSON’S DISEASE.
- Published in:
- Clinical Neuroscience / Ideggyógyászati Szemle, 2022, v. 75, n. 1/2, p. 39, doi. 10.18071/isz.75.0039
- By:
- Publication type:
- Article
48
APPLICATION OF STABILITY INDICATING HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHIC METHOD FOR QUANTITATION OF PRAMIPEXOLE IN PHARMACEUTICAL DOSAGE FORM.
- Published in:
- Journal of Liquid Chromatography & Related Technologies, 2011, v. 34, n. 16, p. 1664, doi. 10.1080/10826076.2011.576301
- By:
- Publication type:
- Article
49
Factors associated with severity of daytime sleepiness and indications for initiating treatment in patients with periodic limb movements during sleep.
- Published in:
- Sleep & Biological Rhythms, 2012, v. 10, n. 3, p. 187, doi. 10.1111/j.1479-8425.2012.00560.x
- By:
- Publication type:
- Article
50
Pramipexole reduces inflammation in the experimental animal models of inflammation.
- Published in:
- Immunopharmacology & Immunotoxicology, 2017, v. 39, n. 2, p. 80, doi. 10.1080/08923973.2017.1284230
- By:
- Publication type:
- Article